TickerFactsScreenerDevelopers

ALX ONCOLOGY HOLDINGS INC (ALXO) — Shareholders' Equity

Annual figures by fiscal year, from SEC filings.

2017: -$38.41M2018: -$51.78M2019: -$70.64M2020: $429.85M2021: $363.05M2022: $263.46M2023: $189.71M2024: $113.62M2025: $25.98M$25.98M
2017Shareholders' Equity (USD)2025
Fiscal YearShareholders' EquityChange YoY
2025$25.98M-77.1%
2024$113.62M-40.1%
2023$189.71M-28.0%
2022$263.46M-27.4%
2021$363.05M-15.5%
2020$429.85M+708.5%
2019-$70.64M-36.4%
2018-$51.78M-34.8%
2017-$38.41M—